InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by McCracken Joseph S, 董事. Officer active across 5 companies, notably LUMOS PHARMA, INC.. Cumulatively, 12 filings have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €169k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 16 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Joseph S McCracken is Administrateur at Savara Inc, Lumos Pharma, INC. and Nexvet Biopharma plc. He has 12 filings in total, and across the 12 recent filings included here, the activity is mainly acquisitions, with EUR 168861 of buys and EUR 0 of sells between 2016-01-05 and 2026-02-17.